Pharmacoeconomics Status in Asia and an Emerging Hub in the Indo-Pak

被引:0
作者
Sadia, Halima [1 ]
Rehman, Hina [2 ]
Naveed, Safila [3 ]
机构
[1] Jinnah Univ Women, Fac Pharm, Dept Pharm Practice, Nazimabad 5C, Karachi 74600, Sindh, Pakistan
[2] Jinnah Sindh Med Univ, Fac Pharm, Dept Pharm Practice, Rafiqui Shaheed Rd, Karachi, Pakistan
[3] Jinnah Univ Women, Fac Pharm, Dept Pharmaceut Chem, Nazimabad 5C, Karachi, Pakistan
关键词
Asia; Development; India; Pakistan; Pharmacoeconomics; Opportunities; HEALTH TECHNOLOGY-ASSESSMENT; PHARMACEUTICAL-INDUSTRY; DRUG DEVELOPMENT; COST; CARE; DECISION; QUALITY;
D O I
10.5530/ijper.53.3.71
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Objective: A review has been carried out to understand pharmacoeconomics and its development in the Asian region. Findings: Pharmacoeconomics is a subset of health economics which applies the methodologies and principles of health economics in clinical decision making. Currently, a number of countries around the globe have implemented pharmacoeconomics in their health care systems. However, the development of pharmacoeconomics in the Asia is very debatable. With countries like South Korea, Japan, China and Thailand where health economics is not only being implemented but is also progressing very rapidly, the southern part of Asia specifically India and Pakistan are far behind. Summary: Pharmacoecomics is in very infancy in the South Asia especially in India and Pakistan. It is the need of the hour to improve the practice and development of new pharmacoeconomics guidelines to meet up the standards of the remaining world.
引用
收藏
页码:376 / 381
页数:6
相关论文
共 50 条
  • [1] Estimating the cost of new drug development: Is it really $802 million?
    Adams, CP
    Brantner, VV
    [J]. HEALTH AFFAIRS, 2006, 25 (02) : 420 - 428
  • [2] Ahuja J, 2004, NATL MED J INDIA, V17, P80
  • [3] [Anonymous], 2016, Value Health Reg Issues, V9, P112, DOI 10.1016/j.vhri.2016.04.001
  • [4] [Anonymous], GLOB HLTH EXP DAT
  • [5] [Anonymous], 2011, J PHARM EC
  • [6] [Anonymous], 2013, ESSENTIALS PHARMACOE
  • [7] Pharmacoeconomics - an aid to better decision-making
    Arenas-Guzman, R
    Tosti, A
    Hay, R
    Haneke, E
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 : 34 - 39
  • [8] Bhowmik D, 2014, PHARMACY, V69, P23672
  • [9] PHARMACOECONOMICS AND OUTCOMES RESEARCH
    BOOTMAN, JL
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 : S16 - S19
  • [10] Bootman JL, 2004, PRINCIPLES PHARMACOE